Coach, Inc. (NYSE:COH), a leading New York design house of modern luxury accessories, announced sales of $1.10 billion for its third fiscal quarter ended March 29, 2014, compared with $1.19 billion reported in the same period of the prior year, a decrease of 7%. On a constant currency basis sales declined 5% for the quarter. Net income for the quarter totaled $191 million, with earnings per diluted share of $0.68. This compared to net income of $239 million and earnings per diluted share of $0.84, in the prior year’s third quarter. Coach Inc (NYSE:COH) shares after opening at $49.85 moved to $50.60 on last trade day and at the end of the day closed at $50.42. Company price to sales ratio in past twelve months was calculated as 2.81 and price to cash ratio as 17.52. Coach Inc (NYSE:COH) showed a positive weekly performance of 2.67%.
Archer Daniels Midland Company (NYSE:ADM) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement. Archer Daniels Midland Company (NYSE:ADM) shares fell -0.09% in last trading session and ended the day on $44.38. ADM return on equity ratio is recorded as 6.90% and its return on assets is 3.20%. Archer Daniels Midland Company (NYSE:ADM) yearly performance is 35.47%.
Sprint Corporation ( NYSE:S) will host a conference call at 8:00 AM ET on April 29, 2014, to discuss its Q1 14 earnings results. Sprint Corporation (NYSE:S) shares moved down -4.99% in last trading session and was closed at $7.43, while trading in range of $7.38-$7.95. Sprint Corporation (NYSE:S) year to date performance is -30.88%.
Pharmacyclics (NASDAQ:PCYC)‘s stock had its “neutral” rating restated by Zacks in a research report issued on Monday. They currently have a $93.00 target price on the stock. Zacks‘s price objective points to a potential upside of 4.85% from the stock’s previous close.Pharmacyclics, Inc. (NASDAQ:PCYC) weekly performance is 3.03%. On last trading day company shares ended up $91.70. Pharmacyclics, Inc. (NASDAQ:PCYC) distance from 50-day simple moving average is -21.78%. Analysts mean target price for the company is $163.75.
Leave a Reply